Seeking Alpha

M. E. Garza's  Instablog

M. E. Garza
Send Message
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began... More
My company:
BioMedReports.Com
My blog:
Daily Info Feeds and Updates
  • RxNews Recap for Wednesday 12-02-09 0 comments
    Dec 4, 2009 5:38 PM | about stocks: VRTX, HSP, PPDI, INCY, ABC, BMY, ABMD, PPG
    Below is a list of the healthcare sector companies that made news in the healthcare sector on Wednesday, December 12, 2009. This list feature is meant to help investors keep tabs on the sector without having to scour through all the press releases.

    Genta Incorporated (OTCBB:GETA) announced that the Company will supply Ganite® (gallium nitrate injection) for a new clinical trial that will be initiated in patients with cystic fibrosis (NYSE:CF) who may develop serious infections.

    Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today provided updates on the regulatory review and approval, or commissioning, of Alexion’s Rhode Island manufacturing facility (ARIMF) in Smithfield, Rhode Island as a second source of supply for Soliris® (eculizumab).

    Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today provided information on its financial performance for the third quarter and nine months ended September 30, 2009.

    Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV), a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, for the management of acute moderate-to-severe pain in adults.

    Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, reported today that it has settled pending litigation with K & D Equity Investments, Inc. and South Beach Live, Inc., and reached agreements with its largest creditors to convert their debt for shares.

    Phosphagenics Limited (“Phosphagenics”) (ASX: POH; OTCQX: PPGNY) today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.

    Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced availability of a webcast with results from USpella, the first U.S. multicenter registry of Impella 2.5 patients evaluating the safety and feasibility of left ventricular support with the Impella 2.5 during high-risk percutaneous coronary intervention (NYSE:PCI) and treatment of acute myocardial infarction (AMI).

    CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), following the U.S. Food and Drug Administration’s (FDA) acceptance of a revised clinical trial protocol.

    Bristol-Myers Squibb Company (NYSE: BMY) today announced that more than 80 abstracts highlighting compounds from the company’s oncology portfolio will be presented at the 51st Annual Meeting of the American Society of Hematology (NYSE:ASH) to be held December 5-8 in New Orleans.

    AmerisourceBergen (NYSE: ABC) today announced that it will hold its annual Investor Day in New York on Tuesday, December 15, 2009. The event will be webcast live beginning at 12:30 pm EST and ending at approximately 3:00 pm.

    Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled a webcast for 8:30 p.m. CT / 9:30 p.m. ET on Monday, December 7, 2009 to discuss clinical results for its lead JAK 1/JAK 2 inhibitor, INCB18424, which will be the subject of three oral presentations at the 51st American Hematology Annual Meeting in New Orleans.

    PPD, Inc. (NASDAQ: PPDI) today announced it has launched a new global information technology infrastructure for analysis and reporting of clinical trial data.

    Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it intends to offer, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering under an effective shelf registration statement on file with the Securities and Exchange Commission.

    Hospira, Inc. (NYSE:HSP), a leading provider of clinical information and medication delivery technologies, announced today that it has acquired Salt Lake City-based TheraDoc, a clinical informatics company that develops hospital surveillance systems.


    Themes: healthcare Stocks: VRTX, HSP, PPDI, INCY, ABC, BMY, ABMD, PPG
Back To M. E. Garza's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • Hearing some interesting developments on the horizon for $NWBO. Did an article on them yesterday. Looks promising. http://bit.ly/NWBOnews
    Jul 12, 2011
  • ($RXPC.PK 3 of 3) If it were bad news, chances are they'd have something by now, since delisting decisions are usually handed down quickly.
    Apr 19, 2011
  • ($RXPC.PK 2 of 3) a listing extension would go until July [when the stock would have to be over $1 to continue being listed on Amex].
    Apr 19, 2011
More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.